The biosynthetic implications of acetate and glutamate incorporation into (3R, 5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by serratia sp

39Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Two new β-lactams have been isolated from strains of Serratia and Erwinia sp. and identified as (3R, 5R)- and (3S, 5R)-carbapenam-S-carboxylic acid. These novel carbapenams lack antibacterial activity, are resistant to both β-lactamases I and II from Bacillus cereus and are not detected by the lactamase induction assay. Radiolabelled and stable isotope experiments have established that both metabolites together with the antibiotic 5R-carbapenem-3-carboxylic acid are glutamate and acetate derived. A number of possible pathways for the biosynthesis of these compounds as well as their relationship to the more complex members of the carbapenem family of β-lactam antibiotics are discussed. © 1988, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Bycroft, B. W., Maslen, C., Box, S. J., & Brown, A. (1988). The biosynthetic implications of acetate and glutamate incorporation into (3R, 5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by serratia sp. The Journal of Antibiotics, 41(9), 1231–1242. https://doi.org/10.7164/antibiotics.41.1231

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free